Flora Growth Corp. (FLGC) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FLGC SEC filings page.
Flora Growth Corp. (FLGC) reported $36.1M in revenue over the twelve months to Mar 31, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Flat sales now produce almost no gross profit, while a reported operating loss far exceeds cash consumed.
Revenue was nearly unchanged from FY2024 to FY2025, but gross margin compressed from6.1% to4.6% , leaving little room to absorb overhead. At the same time, operating loss reached$154.7M while operating cash flow was-$8.7M , a gap that points to a large non-cash or accrual operating charge rather than equivalent cash deterioration.
FY2025 operating cash flow was
Total assets rose from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Flora Growth Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Flora Growth Corp. held $5.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $8.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Flora Growth Corp. scores 25/100 among other emerging companies.
Flora Growth Corp. had 1M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Flora Growth Corp. scores 94/100 among other emerging companies.
Not available for Flora Growth Corp., and counted as zero in the overall score.
Flora Growth Corp. reported revenue of $35.7M in fiscal year 2025, against $35.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Flora Growth Corp. scores 12/100 among other emerging companies.
Flora Growth Corp.'s operations used $8.7M of cash in fiscal year 2025, against $5.0M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Flora Growth Corp. scores 43/100 among other emerging companies.
Flora Growth Corp.'s cash, cash equivalents and investments came to $5.6M at the end of fiscal year 2025, against $59.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Flora Growth Corp. scores 17/100 among other emerging companies.
Flora Growth Corp. scores -6.41, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($21.6M) relative to total liabilities ($59.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Flora Growth Corp. passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Flora Growth Corp. reported a net loss of $119.7M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Flora Growth Corp. reported an operating loss of $154.7M against $243K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Flora Growth Corp. generated $7.3M in revenue in Q1 2026. This represents an increase of 5.9% from the same quarter a year earlier. Against the prior quarter it is up 70.5%.
Flora Growth Corp.'s EBITDA was -$62.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4259.7% from the same quarter a year earlier. Against the prior quarter it is up 57.4%.
Flora Growth Corp. reported -$36.7M in net income in Q1 2026. This represents a decrease of 4736.4% from the same quarter a year earlier. Against the prior quarter it is up 66.6%.
Cash & Balance Sheet
Flora Growth Corp. recorded an outflow of $3.8M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 43.3% from the same quarter a year earlier. Against the prior quarter it is down 20.6%.
Flora Growth Corp. held $2.0M in cash against $38K in long-term debt as of Q1 2026, with $8.1M of liabilities due within a year.
Not reported for Q1 2026.
Margins & Returns
Flora Growth Corp.'s gross margin was 43.3% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 35.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 91.3 percentage points.
Flora Growth Corp.'s ROE was -99.6% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 83.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 56.1 percentage points.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Flora Growth Corp. reported no capital expenditure in Q1 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Not reported for Q1 2026.
Not reported for Q1 2026.
FLGC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3M+5.9% | $4.3M | $9.7M+34.7% | $14.8M-5.7% | $6.9M-61.9% | N/A | $7.2M-58.2% | $15.7M-26.9% |
| Cost of Revenue | $4.1M-34.8% | $6.3M | $9.4M+39.6% | $12.0M-4.4% | $6.3M-55.3% | N/A | $6.7M-45.5% | $12.5M-28.5% |
| Gross Profit | $3.1M+488.0% | -$2.1M | $335K-32.3% | $2.8M-10.6% | $535K-86.1% | N/A | $495K-90.0% | $3.2M-20.0% |
| R&D Expenses | N/A | N/A | N/A | $73K+17.7% | $113K+140.4% | N/A | $118K+1375.0% | $62K+376.9% |
| SG&A Expenses | N/A | -$312K | $473K+15.6% | $760K+29.5% | $470K+6.3% | N/A | $409K+20.3% | $587K-14.3% |
| Operating Income | -$62.7M-3769.9% | -$147.2M | -$3.3M-54.3% | -$2.6M+27.5% | -$1.6M+34.8% | N/A | -$2.1M-291.9% | -$3.5M+91.2% |
| EBITDA | -$62.6M-4259.7% | -$147.0M | -$3.3M-54.6% | -$2.4M+27.7% | -$1.4M+40.4% | N/A | -$2.1M-797.0% | -$3.3M+91.6% |
| Interest Expense | $66K+29.4% | -$137K | -$61K-134.6% | -$96K-155.8% | $51K+8.5% | N/A | -$26K | $172K+855.6% |
| Income Tax | -$9K-110.2% | $1K | $18K+127.3% | -$48K-37.1% | $88K-31.3% | N/A | -$66K-29.4% | -$35K+96.9% |
| Net Income | -$36.7M-4736.4% | -$109.9M | -$6.7M-76.5% | -$2.4M+8.3% | -$758K+77.5% | N/A | -$3.8M-405.0% | -$2.6M+94.1% |
| EPS (Basic) | -$3.68-139.0% | N/A | -$9.05+18.0% | -$0.11+47.6% | -$1.54-305.3% | N/A | -$11.03-6227.8% | -$0.21+96.8% |
| EPS (Diluted) | -$3.68 | N/A | -$9.05 | -$0.11 | -$1.54 | N/A | -$11.03 | -$0.21 |
| Diluted Shares (Avg) | 9,958 | N/A | 736 | 21,454 | 492 | N/A | 342 | 12,278 |
FLGC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.2M+101.8% | $130.2M+396.6% | $74.0M+152.8% | $22.7M-24.7% | $22.4M-7.7% | $26.2M+11.0% | $29.3M-7.3% | $30.1M-1.3% |
| Current Assets | $11.2M-14.9% | $8.7M-55.9% | $18.1M-15.0% | $13.2M-38.2% | $13.2M-39.3% | $19.8M-7.5% | $21.3M-10.8% | $21.4M-4.0% |
| Cash & Equivalents | $2.0M-46.2% | $5.6M+7.1% | $13.1M+211.2% | $1.5M-76.0% | $3.7M-11.5% | $5.2M+20.1% | $4.2M-11.6% | $6.1M+243.8% |
| Inventory | $1.6M-66.4% | $1.9M-15.3% | $2.5M-68.4% | $4.8M-28.8% | $4.8M-48.2% | $2.2M-73.7% | $7.9M-26.1% | $6.7M-22.3% |
| Accounts Receivable | $783K-80.7% | $799K-49.0% | $2.3M-41.6% | $5.1M+55.1% | $4.0M+25.8% | $1.6M-60.3% | $3.9M+10.7% | $3.3M-32.4% |
| Goodwill | N/A | N/A | N/A | $4.7M+104.9% | $4.5M | $2.0M | $2.1M | $2.3M |
| Total Liabilities | $8.4M-52.4% | $59.7M+174.8% | $9.1M-62.3% | $18.6M-14.5% | $17.6M-16.6% | $21.7M+26.1% | $24.1M+30.4% | $21.8M+7.7% |
| Current Liabilities | $8.1M-35.6% | $8.6M-54.2% | $8.7M-58.4% | $13.8M-24.9% | $12.6M-34.8% | $18.8M+15.7% | $20.9M+26.0% | $18.4M+3.1% |
| Non-Current Liabilities | $289K-94.3% | $51.1M+1669.7% | $399K-87.5% | $4.8M+41.2% | $5.0M+177.8% | $2.9M+206.3% | $3.2M+69.0% | $3.4M+41.3% |
| Long-Term Debt | $38K-86.2% | $50.8M | $64K | $326K | $275K | $0 | N/A | N/A |
| Total Equity | $36.8M+673.4% | $70.6M+1464.3% | $64.9M+1427.5% | $4.0M-45.0% | $4.8M+51.6% | $4.5M-29.6% | $4.3M-70.3% | $7.3M-33.2% |
| Retained Earnings | -$314.4M-97.9% | -$277.8M-75.7% | -$167.9M-10.4% | -$161.3M-8.8% | -$158.9M-9.1% | -$158.1M-10.9% | -$152.0M-13.7% | -$148.2M-7.2% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
FLGC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.8M-44.6% | -$3.2M-134.8% | $100K+104.8% | -$3.0M-1015.1% | -$2.7M-98.6% | -$1.3M-19.0% | -$2.1M-501.7% | -$265K+92.3% |
| Depreciation & Amortization | $4K-97.8% | $198K | $7K-12.5% | $195K-24.1% | $182K+145.9% | N/A | $8K-97.4% | $257K-70.6% |
| Stock-Based Compensation | $2.8M+1511.0% | N/A | $541K+33.3% | $172K+1333.3% | $172K+1620.0% | N/A | $406K+10050.0% | $12K-96.4% |
| Capital Expenditures | $0-100.0% | $29K | $9K-55.0% | $65K+150.0% | $24K-72.7% | $0-100.0% | $20K+233.3% | $26K-72.0% |
| Free Cash Flow | -$3.8M-43.3% | -$3.2M-136.9% | $91K+104.3% | -$3.0M-937.8% | -$2.7M-88.0% | -$1.3M-15.1% | -$2.1M-510.4% | -$291K+91.8% |
| Investing Cash Flow | $0-100.0% | -$2.8M | -$11K-104.7% | -$1.0M-1929.1% | $370K+520.5% | $0-100.0% | $236K+406.5% | $55K+159.1% |
| Financing Cash Flow | $571K | -$719K-121.3% | $10.6M+4207.0% | $1.5M-66.8% | $0+100.0% | $3.4M+380.5% | -$257K-111.0% | $4.6M+3377.9% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
FLGC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.3%+35.5pp | -48.1% | 3.4%-3.4pp | 19.1%-1.1pp | 7.8%-13.6pp | N/A | 6.8%-21.7pp | 20.2%+1.7pp |
| Operating Margin | -861.3% | -3450.6% | -33.5%-4.3pp | -17.3%+5.2pp | -23.6%-9.8pp | N/A | -29.2%-26.1pp | -22.6% |
| Net Margin | -504.0% | -2576.3% | -68.3%-16.2pp | -16.3%+0.5pp | -11.0%+7.7pp | N/A | -52.1%-59.3pp | -16.8% |
| Return on Equity | -99.6%-83.7pp | -155.8% | -10.3%+78.5pp | -60.0%-24.0pp | -15.9%+91.6pp | N/A | -88.8%-97.4pp | -36.0%+369.1pp |
| Return on Assets | -81.1%-77.7pp | -84.4% | -9.0%+3.9pp | -10.6%-1.9pp | -3.4%+10.5pp | N/A | -12.9%-16.8pp | -8.7%+136.6pp |
| Current Ratio | 1.39+0.3x | 1.010.0x | 2.08+1.1x | 0.96-0.2x | 1.05-0.1x | 1.05-0.3x | 1.02-0.4x | 1.16-0.1x |
| Debt-to-Equity | 0.00-0.1x | 0.72+0.7x | 0.00-5.7x | 0.08-2.9x | 0.06-6.7x | 0.00-2.7x | 5.67+4.4x | 2.98+1.1x |
| Asset Turnover | 0.16-0.1x | 0.03 | 0.13-0.1x | 0.65+0.1x | 0.31-0.4x | N/A | 0.25-0.3x | 0.52-0.2x |
| FCF Margin | -52.9%-13.8pp | -74.8% | 0.9%+30.0pp | -20.4%-18.6pp | -39.1%-31.2pp | N/A | -29.0%-32.0pp | -1.9%+14.7pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Flora Growth Corp. FLGC | FY2025 | $35.7M | -$119.7M | N/A | $21.6M | 32/100 |
| TherapeuticsMD, Inc. TXMD | FY2025 | $3.0M | -$569K | -18.8% | $23.7M | 63/100 |
| Gelteq Limited GELS | FY2025 | N/A | -$6.6M | N/A | $5.6M | — |
| Biofrontera Inc. BFRI | FY2025 | $41.7M | -$10.5M | -25.3% | $15.1M | 39/100 |
| AYTU BioPharma, Inc. AYTU | FY2026 | $57.6M | -$14.3M | -24.8% | $22.5M | 47/100 |
Where Flora Growth Corp. Ranks
Frequently Asked Questions
What is Flora Growth Corp.'s annual revenue?
Flora Growth Corp. (FLGC) reported $35.7M in total revenue for fiscal year 2025. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Flora Growth Corp.'s revenue growing?
Flora Growth Corp. (FLGC) revenue declined by 0.5% year-over-year, from $35.9M to $35.7M in fiscal year 2025.
Is Flora Growth Corp. profitable?
No, Flora Growth Corp. (FLGC) reported a net income of -$119.7M in fiscal year 2025.
What is Flora Growth Corp.'s EBITDA?
Flora Growth Corp. (FLGC) had EBITDA of -$154.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Flora Growth Corp. have?
As of fiscal year 2025, Flora Growth Corp. (FLGC) had $5.6M in cash and equivalents against $50.8M in long-term debt.
What is Flora Growth Corp.'s gross margin?
Flora Growth Corp. (FLGC) had a gross margin of 4.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Flora Growth Corp.'s return on equity (ROE)?
Flora Growth Corp. (FLGC) has a return on equity of -169.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Flora Growth Corp.'s free cash flow?
Flora Growth Corp. (FLGC) recorded an outflow of $8.8M in free cash flow during fiscal year 2025. This represents a -70.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Flora Growth Corp.'s operating cash flow?
Flora Growth Corp. (FLGC) recorded an outflow of $8.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Flora Growth Corp.'s total assets?
Flora Growth Corp. (FLGC) had $130.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Flora Growth Corp.'s capital expenditures?
Flora Growth Corp. (FLGC) invested $127K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Flora Growth Corp.'s current ratio?
Flora Growth Corp. (FLGC) had a current ratio of 1.01 as of fiscal year 2025, which is considered adequate.
What is Flora Growth Corp.'s debt-to-equity ratio?
Flora Growth Corp. (FLGC) had a debt-to-equity ratio of 0.72 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Flora Growth Corp.'s return on assets (ROA)?
Flora Growth Corp. (FLGC) had a return on assets of -91.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Flora Growth Corp.'s Altman Z-Score?
Flora Growth Corp. (FLGC) has an Altman Z-Score of -6.41, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Flora Growth Corp.'s Piotroski F-Score?
Flora Growth Corp. (FLGC) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Flora Growth Corp.'s earnings high quality?
Flora Growth Corp. (FLGC) reported a net loss of $119.7M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Flora Growth Corp. cover its interest payments?
Flora Growth Corp. (FLGC) reported an operating loss of $154.7M against $243K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Flora Growth Corp.?
Flora Growth Corp. (FLGC) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.